Dr Jim Freeth

Biog:
Jim is Managing Director of Retrogenix, having co-founded the company in 2008. This followed 10+ years in management within the biotechnology (Oxford BioMedica) and pharmaceutical industries (AstraZeneca). He is a biologist by training, and obtained his PhD at Manchester University, UK, in 1997. Jim has had a long-standing involvement and interest in phenotypic drug discovery and target deconvolution.